Sie sind auf Seite 1von 31

Effective Investigations

and
Corrective Actions (CAPA)
P
Proper
Investigation
I
i i off Quality
Q li E
Events
Michael H. Anisfeld
Globepharm Consulting

What Do You Do When The Bad Stuff Happens?

Pretend It Never Happened

Ignore
It
I

!#&*!$%...

Curse

Advise Boss

Advise Your Buddy


Walk Away
Fix It

Its a One-Off
Investigate + Fix

Blame Someone Else

Investigate

Investigate, Fix + Document

Copyright, Globepharm Consulting, 2008

Failure/Deviation System

The purpose of
Th
f a failure/deviation
f il
/d i i system is
i
to assure that each failure/deviation does not
adversely impact product quality and that
effective corrective action is taken to reduce
the probability of such failure in the future

Copyright, Globepharm Consulting, 2008

Contributors to Failure

Materials
Facilities
Equipment
Instrumentation
People
Processes
Procedures

Failure / Deviation
Definition

F il
Failure
Product does not meet specification.
Failure may be detected in/by
Production
Laboratory

Deviation
Change in procedures, equipment, materials,
personnel related to product manufacture having
an impact on product quality
6

Copyright, Globepharm Consulting, 2008

Definitions
Immediate Cause
Situation directly causing the problem
Root Cause
Basic Causal Factor, which if corrected or removed prevents a
repeat of the problem
Intermediate Cause
Reason for problem at more fundamental level than the
immediate cause, but not the root cause [why-2, why-3]
Root Cause Analysis
Structured questioning process enabling identification of
underlying beliefs and practices that result in poor quality
7

Causes of Failure

Common
C
mm n Cause
C
[End mi S
[Endemic
Systematic]
t m ti ] (Variation)
(V i ti n)
Originates from the basic elements of the process:
Machines
Materials
Methods
Manpower
Measurement

Assignable Cause [Special] (Variation)


An unplanned variation originating outside expected
operating process conditions [special cause variation]
8

Copyright, Globepharm Consulting, 2008

Failure/Deviations

Measures

There are three key steps in this process and each of these should
be monitored regularly
Recording the failures and deviations
Total number
Number by department

Action on product batch(es) involved

Audit by sampling to verify that corrective action was taken

Corrective action on root causes

There should be an elimination of failures/deviations due to causes


for which corrective actions have been implemented

Regulators Expectations

Comprehensive,
C
h
i
H
Honest A
Approach
h To
T
Investigate OOS Results/Failures
Evaluation Using Scientifically Valid Principles
Learning From Experiences
Permanent Solutions To Problem
Authorities Not The Ones To Find The
Problem
10

Copyright, Globepharm Consulting, 2008

11

What to Do
When the Unexpected Happens

UNEXPECTED?
OOS

Laboratory
Manufacturing

OOT
OOE
OOY

Water System

Reconciliation Yield Check


Reconciliation Packaging Material

Deviation
Discrepancy
Unusual Event
12

Copyright, Globepharm Consulting, 2008

13

What Do The US Regulations Say?

Investigation
In
ti ti n specifically
p ifi ll stated
t t d in the
th cGMPs:
GMP :
211.22
211.125
211.170
211.180
211.186
211.188
211.192
211.198
211.204

Responsibilities of quality control unit.


Labeling issuance.
Reserve samples.
General requirements.
Master p
production and control records.
Batch production and control records.
Production record review.
Complaint files.
Returned drug products.
14

Copyright, Globepharm Consulting, 2008

What Does The EU Guide Say?

I
Investigation
ti ti specifically
ifi ll stated
t t d iin th
the GMP
GMPs:
1.3 Quality Assurance
1.4 Quality Control
2.7 Production/QC Responsibilities
5 39 Production
5.39
5.56 Packaging Operations
6.2 Quality Control
8.1 Complaints
15

Future Regulations

An international
i
i
l harmonized
h
i d
approach to

Risk Management

ICH-Q9
16

Copyright, Globepharm Consulting, 2008

ICH-Q9
Risk Management

initiate
risk management process
risk assessment

Risk man
nagement tools
s

risk identification
risk analysis
risk evaluation

unacceptable

risk control
risk reduction
risk
i k acceptance
t
risk communication
risk communication
output/results of the
risk management process

Copyright, Globepharm Consulting, 2008

OK

risk acceptance
review event
17

CAPA

19

How do you know


whats happening?

R
Recognize
i
that
h there
h
is
i a problem:
bl
Capture The Data
Analyze The Data
Trend The Data

Then
hen Fix the problem
problem:
Investigate the Cause
Attempt to Get to Root Cause
Implement Effective Fixes
Monitor the Fix
20

Copyright, Globepharm Consulting, 2008

10

21CFR820.100 - CAPA
820.100 Corrective and preventive action
(a) Each manufacturer shall establish and maintain procedures
for implementing corrective and preventive action. The
procedures shall include requirements for:
(1) Analyzing processes, work operations, concessions,
quality audit reports, quality records, service records,
complaints, returned product, and other sources of quality
data to identify existing and potential causes of
g p
product,, or other quality
q
y problems.
p
nonconforming
Appropriate statistical methodology shall be employed
where necessary to detect recurring quality problems;
(2) Investigating the cause of nonconformities relating to
product, processes, and the quality system;
(3) Identifying the action(s) needed to correct and
prevent recurrence of nonconforming product and other
quality problems;

21

21CFR820.100 - CAPA
820.100 Corrective and preventive action (continued)
(4) Verifying or validating the corrective and preventive action
to ensure that such action is effective and does not adversely
affect the finished device;
(5) Implementing and recording changes in methods and
procedures needed to correct and prevent identified quality
problems;
(6) Ensuring that information related to quality problems or
nonconforming
f mi product
d t iis disseminated
di
mi t d to
t th
those di
directly
tl
responsible for assuring the quality of such product or the
prevention of such problems; and
(7) Submitting relevant information on identified quality
problems, as well as corrective and preventive actions, for
management review.
(b) All activities required under this section, and their results,
shall be documented

Copyright, Globepharm Consulting, 2008

22

11

CAPA Analyzing Sources


of Quality Data
Environmental
E i
l
Monitoring

Complaints/
Returns
Repairs/
Ser icing
Servicing

Process
Deviations
or Failures

Acceptance
Activities

CAPA

Stability
Data

Calibration/
Maintenance
Audits

Yields/Scrap
23

What To Track

T
Track
k By:
B
Product

In-process, release, stability, validation

Event

Reason for investigation

Operator/Analyst

If cause is operator/analyst error

Instrument/Equipment

If cause instrument related

Cause

Investigation conclusion

Corrective Action

Remedy and prevention

Timeliness

Time to complete investigations


24

Copyright, Globepharm Consulting, 2008

12

CAPA Data Collection


Incidents Reported - 2003

Question:

250
200

Are we Getting Better as a Company?


Or Dropping Off in Capturing Incidents?

210
186

178

165 171

150

143

Incidents

132 130

100

119

98

85

92

50
0
Jan Feb Mar Apr May Jun

Jul

Aug Sep Oct Nov Dec


25

Run Charts: Trend Charts

Environmental Data Purified Water System

Specification
Upper Limit

OOT? / OOE?

Specification
Lower Limit

26

Copyright, Globepharm Consulting, 2008

13

Tracking / Trending

Paper/Pen
Spreadsheet (Excel, Oracle)
Dedicated Computer Systems
Trackwise

(Sparta Systems: http://www.sparta-systems.com)

CATSweb

(AssurX: http://www.assurx.com/catsweb.html)
p

MetricStream

(Metric Stream: http://www.metricstream.com)

SmartCAPA

(SmartCAPA: http://www.pilgrimsoftware.com)

Others ..
27

SmartCAPA
(www.pilgrimsoftware.com)

28

Copyright, Globepharm Consulting, 2008

14

29

Purpose of Investigation

The
Th purpose of
f an investigation
i
i
i it
i to
determine the cause of the failure.
Even if the batch is rejected based on the OOS
result, the investigation is necessary to determine
if the result is associated with other batches of
the same drug product or other products

FDA: Draft OOS Guideline, September 1998


30

Copyright, Globepharm Consulting, 2008

15

Failure / Deviation What To Do

Failure/Deviation
Detected
F il
/D i ti
D t t d

I f
Inform
QA
24 hours

Perform Investigation

Batch Disposition
Immediate Fix

Root Cause Analysis

30 days

Communicate to Management
Corrective/Preventive Action
Assess Effectiveness of Fix
31

Investigations:
Youve Got to Be A Detective!

32

Copyright, Globepharm Consulting, 2008

16

Investigations 101

P p
Purpose
off ann In
Investigation
ti ti n
Obtain facts as to cause
Common
Special - Assignable

Process of an Investigation

Complete
p
description
p
of problem
p
Validity of inputs
Review key process variables
Determine scope of investigation
Document investigation
33

Learn How To Be A Detective

What Equipment,
Equipment
Machine, Tool?
What Is Wrong?
What Is the
Complaint?
What is the Undesired
Behavior?
34

Copyright, Globepharm Consulting, 2008

17

Learn How To Be A Detective

Wh is
Who
i Involved?
I
l d?
Staff
Consultants
Vendors
Visitors

Name names/positions!

35

Learn How To Be A Detective

When does
Wh
d
the
th problem
bl
occur?
Day
Date
Time
Shift
Phase of operation
When in equipment life
cycle

Are there time patterns?


36

Copyright, Globepharm Consulting, 2008

18

Learn How To Be A Detective

Whi h
Which:
Unit
Area
Department
Line
Machine

Location of defective
item, or where on
defective item
37

Learn How To Be A Detective

How is the what


what or who
who
impacted?

Injury / Death
Shut-Down /Start-Up
Damage
Type
Classification of Defects

How Much
How Many
How Big An Issue

What resources are needed


to handle/resolve the issue!
38

Copyright, Globepharm Consulting, 2008

19

Change Analysis

PROBLEM?
E

COMPARISON?

WHAT?

What is the object or


process with the problem?
What is wrong?

What similar object or


process doesnt have the
problem? What else could be
wrong?

WHERE?

Where does the problem


occur

Where else could the


problem occur?

WHEN?

When did the problem


happen?

When did the problem not


happen?

How large is the problem?

How large could it be?

HOW BIG?

39

Investigation Documentation

E
40

Copyright, Globepharm Consulting, 2008

20

Investigation Documentation

Date
D
t p
problem
bl m occurred
d
Statement of the Problem
Listing of batches impacted
List of personnel interviewed
Statement of each persons opinions and memory of event
Discussion of potential causes
Discussion of potential impact
Discussion of extent of problem
Recommendations for fixes
Statement of actions taken to fix
Final decisions regarding batch
Management approvals
41

42

Copyright, Globepharm Consulting, 2008

21

Root Cause Analysis

Corrective
C
ti actions
ti
tto observations
b
ti
((usually
ll symptoms)
t
)
have limited effect on sustained improvement or
elimination of recurrence of the failure
Corrective actions need to address the underlying
causes and root causes of a problem in order to
eliminate the situation from recurring

43

Root Cause Analysis


Equipment

Design, Capability
Design
Maintenance
Operator Error

Procedures

No Procedure
Wrong Procedure Used
Procedure Not Available
Procedure Difficult To Use

Training

None
When
Effectiveness

Quality Control

Inspection Required
Inspection Performed

Management Systems

Qualified Supervision
Audits
Feedback
Prior Corrective Actions Taken
Communication
Planning
Process Capability
Adequate Time To Perform Task
Standards

Manpower

Information Available
Adequate
Timely

Personnel Problems
Training
Fail/Safe Processes
Environment
Lighting
Noise

Fatigue

44

Copyright, Globepharm Consulting, 2008

22

Corrective Action

What
level
Wh is
i the
h lowest
l
l
l at which
hi h we
can do something to prevent the
problem from re-occurring?

45

46

Copyright, Globepharm Consulting, 2008

23

Investigation Tools

Brainstorm
B
i t
th
the iissues
Flowcharting
Fishbone Analysis Cause/Effect diagrams
Why-Why Analysis
Pareto Charts
Run Charts
Force Field Analysis
Six-Sigma Analysis - MAIC
Kepner-Tregoe
47

Brainstorming

Possible
P
ibl ttargett questions
ti
to
t serve as the
th focal
f
l point
i t of
f
the brainstorming process:
What would solve the problem?
What strategy could resolve the root cause?
What solutions have already been thought of?
What solutions have not been thought of?
How can we prevent the situation recurring?
What different methods might work?
What crazy ideas might help?
48

Copyright, Globepharm Consulting, 2008

24

Fishbone Analysis

Manpower

Management

People too busy


People not paying attention

Batch
Record
Errors

Methods

Machines
49

Why-Why Analysis

Oil Drops
D
On
O Fl
Floor
Dripping Engine
Oil Can to Collect
Funnel in Oil Can
Raise Funnel
Unless youve gone
5 levels of questions
you probably have
not got to root cause!
50

Copyright, Globepharm Consulting, 2008

25

Pareto Analysis
Pareto: 80 20 rule

Batch Record Problems


87

90
80
70
60
50
40
30

23

20

18

10

12

0
Signatures

Data

Errors

Other

51

Process Shift, F-440 Particle Size

Copyright, Globepharm Consulting, 2008

26

APR Annual Product Review

53

Force-Field Analysis

The
Th Positive/Negative
P iti /N
ti

Analysis for Solutions

can stimulate thinking


just as a the force-field
format did in the past.
Since we are looking for
solutions, the two
columns play better
better
against worse.

What
Wh t would
ld make
k
the problem
better?
1.
2.
3.
4.
5.
6.
7.
8.

What
Wh t would
ld make
k
the problem
worse?
1.
2.
3.
4.
5.
6.
7.
8.
54

Copyright, Globepharm Consulting, 2008

27

Six Sigma Problem Solving MAIC


Measure
(1) Describe the
Problem

A nalyze
(4) Identify Potential
Causes

Improve

(5) Analyze
Existing Data

Control

(9) Determine Best Solution

(12) Implement
Solution

0.251
0 251

IS

IS NOT

Control Plan

0.250

What

Item

Function

(2) Lid

Prevents Spills

Failure Mode
Lid falls off due
to looseness

0.249

Where

Leaks from drinking hole

0.248

When
Extent

12.5

6
Jan '87

Jul '87

Jan '88

Jul '88

Month

Number

Code

Spill when removing lid

(10) Pilot Solution

Burn

Go-no go gauge

Body diameter
to small

Burn

Go-no go gauge

Surfaces too slick

Burn

Sampling Plan

Hole too large

Stain

Pin gauge

Hole has too


direct of path

Stain

Lid diameter
too small

Burn

(above)

Body diameter
to large

Burn

(above)

Material catches

Burn

Sampling Plan

Cause 1 O
Cause 2 X
Cause 3 O
C
Cause 4 X
Cause 5 O

X X O A
O A AO
O AA O
A X O O
O OO X

(11) Verify Solution Works


LSL

15

USL

20

25

30

35

Seal Strength
OC Curve

70

T M B

(8) Collect Additional Data


Until Root Cause Identified

(3) Measure Problem


Magnitude

T M B

Fact 1
Fact 2
Fact 3
Fact 4
Fact 5

FACTS
(1) All Machines
(2) Second Shift
(3) Certain Codes
(4) Started 8/22
(5) Steadily Worse
(6) All Operators

19

T M B

Effects Control

Lid diameter
too large

(7) Compare
Causes to Facts

(6) Construct List of


Verified Facts

(2) Determine When


Problem Started

T M B

Causes

T
O
R
Q
U
E

10.2

K = 20

60

1.0

Upper Control Limit

10.0

50

K = -20

Pa

Radius
9.8

30

9.6
36.0

37.0

38.0

0.5

Lower Control Limit

40

10

Subgroup

15

20

0.0

Percent Defective

10

55

Copyright 2000, Taylor Enterprises Inc.

56

Copyright, Globepharm Consulting, 2008

28

ICH-Q9
Risk Management

initiate
risk management process
risk assessment

Risk man
nagement tools
s

risk identification
risk analysis
risk evaluation

unacceptable

risk control
risk reduction
risk
i k acceptance
t
risk communication
risk communication
output/results of the
risk management process

OK

risk acceptance
review event
57

Tools To Prioritize
Fixes and Efforts

FME
FMEA
- Failure
F il
M
Mode
d Eff
Effect Analysis
l i
FTA

- Fault Tree Analysis

HACCP - Hazard Analysis,


Analysis
Critical Control Points

58

Copyright, Globepharm Consulting, 2008

29

Bibliography
Root Cause Analysis:

- Kepner and Tregoe, The New Rational Manager


- Paradies and Unger, Taproot: The System for Root Cause Analysis,
Problem Investigation & Proactive Improvement
- Ammerman,
Ammerman The
The Root Cause Analysis Handbook
Handbook
- Pokras, Systematic Problem-Solving and Decision-Making

Risk:

McDermott et al., The Basics of FMEA

Human Error:

Lorenzo, ABS Consulting, A Managers Guide to Reducing Human Error

g
Managements
Role:

Harbour and Kieffer, Managing the Quality System

FDA:

Investigating Out of Specification (OOS) Test Results for


Pharmaceutical Production (Guidance), September 1998
Quality Systems Approach to Pharmaceutical GMPs, September 2004
59

Stay In Touch

Michael
H. Ani
Anisfeld
Mi h l H
f ld
Globepharm Consulting
313 Pine Street
Deerfield IL 60015, USA
Phone:
Fax:
E-mail:
Website:

USA +1+847 914 0922


USA +1+847 914 0988

manisfeld@globepharm.org
www.globepharm.org

60

Copyright, Globepharm Consulting, 2008

30

61

Questions?

62

Copyright, Globepharm Consulting, 2008

31

Das könnte Ihnen auch gefallen